ArticleBMC pulmonary medicine2022

Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study.

Wenxian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.